Advertisement
Advertisement

CALC

CALC logo

CalciMedica, Inc. Common Stock

0.60
USD
Sponsored
-0.21
-25.64%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

0.61

+0.01
+1.96%

CalciMedica, Inc. Common Stock Profile

About

CalciMedica Inc. is a clinical-stage biopharmaceutical company. It focused on developing therapies for life-threatening inflammatory diseases with high unmet need. CalciMedica Inc. is based in LA JOLLA, Calif.

Info & Links

CEO

A. Rachel Leheny

Headquarters

505 Coast Boulevard South, Suite 307
La Jolla, CA 92037, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.calcimedica.com

Auditor

Baker Tilly US, LLP

Share holders

67

Employees

16

CalciMedica, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

9.62M

Enterprise Value

8.16M

Enterprise Value/EBITDA(ttm)

-0.37

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-1093.51%

Return on Invested Capital(ttm)

-751.87%

Return on Assets(ttm)

-151.17%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-22.20M

Net Income Available to Common(ttm)

-19.54M

Diluted EPS(ttm)

-1.97

Share Statistics

Beta (5Y Monthly)

0.76

52-Week Change

-61.21%

S&P 500 52-Week Change

20.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

15.80M

Dividend Yield

0.00%

Float4

9.20M

% Held by Insiders

41.55%

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

8.16M

Total Cash Per Share(mrq)

0.52

Total Debt(mrq)

6.70M

Total Debt/Equity(mrq)

-146.06%

Current Ratio(mrq)

3.58%

Quick Ratio(mrq)

3.58%

Book Value Per Share(mrq)

-0.43

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.41

Free Cash Flow(ytd)

-21.21M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement